Abbott Laboratories (ABT)

Financing Cash Flow

-$3.52B

Quarterly · Period ending: · USD

ABT logo

ABT Financing Cash Flow

Latest reported-$3.52B
ABT Quarterly Cash from Financing ($30.90M → -$3.52B)
High-resolution chart · PNG

ABT financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-3,518,000,000
17,313,000,000
-1,397,000,000
-1,760,000,000
-1,097,000,000
-2,055,000,000
-1,861,000,000
-1,576,000,000
-791,000,000
-1,176,000,000
-2,052,000,000
-2,340,000,000
-1,289,000,000
-1,410,000,000
-1,457,000,000
-1,543,000,000
-813,000,000
-3,823,000,000
-1,886,000,000
-1,377,000,000
-1,264,000,000
-967,000,000
-787,000,000
-1,915,000,000
658,000,000
-735,000,000
-2,185,000,000
-513,000,000
-449,000,000
-1,142,000,000
-4,776,000,000
2,471,000,000
-1,631,000,000
-6,455,000,000
-112,000,000
-386,000,000
-384,000,000
-4,399,000,000
13,504,000,000
-746,000,000
-179,000,000
-1,432,000,000
-497,000,000
-815,000,000
-374,000,000
-550,000,000
-700,000,000
-271,000,000
-619,000,000
-1,152,000,000
-1,869,055,000
-558,758,000
464,513,000
-4,732,700,000
2,505,609,000
-2,190,957,000
115,367,000
286,074,000
-1,284,818,000
-2,668,122,000
-1,386,181,000
-684,334,000
-93,314,000
-687,106,000
212,878,000
-520,199,000
503,373,000
-856,333,000
-329,623,000
1,684,602,000
47,875,000
-3,365,194,000
57,683,000
-226,266,000
-455,780,000
-817,974,000
-532,221,000
-506,657,000
2,613,089,000
-1,185,174,000
3,644,410,000
-1,450,398,000
-690,257,000
299,787,000
-1,771,126,000
-430,720,000
-212,833,000
-995,047,000
724,221,000
45,339,000
-897,945,000
59,430,000
-758,521,000
-409,176,000
-881,671,000
-270,512,000
-552,556,000
-605,235,000
-218,222,000
-682,598,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.